Areas of Activity

Roche Pharmaceuticals, with its headquarters in Basel, Switzerland, is one of the world's leading research-focused healthcare groups in the field of diagnostics. As one of the world's largest biotechnology companies, Roche develops innovative and different medicines for oncology, virology, inflammation, metabolism, and central nervous system diseases. Being a world leader in in-vitro diagnostics and tissue-based cancer diagnosis, Roche is also a pioneer in diabetes management.

The distinctive feature of Roche is to make a real difference in the health and quality of life of patients, in light of the principle of excellence in science. Our company's primary goal is to develop more effective treatment options for patients. In this context, Roche's focus is on "adapting treatments to patients" with medically differentiated treatments in order to provide benefits for patients in need. Roche focuses on Pharmaceuticals and Diagnostics to achieve this vision.

Innovation throughout the health spectrum

In order to provide better benefits for patients, Roche maintains an integrated innovation approach throughout the healthcare system, from early diagnosis to disease prevention, diagnosis, treatment, and follow-up. These areas will be linked with each other naturally, being integrated in a way that will provide patients with more effective, safer, and more cost-effective health care services. 


Products with clinical benefits

Despite all the advances made in modern medicine, social and economic factors create the need for new products that are more innovative in the diagnosis and treatment of diseases. Roche has allocated its resources to two areas of intensive research such as pharmaceuticals and diagnostics.

Among these activities, priority is given to areas where the medical needs are met and Roche can make a difference. The aim is to provide new and improved medicines, diagnostic methods, and services that currently available options cannot yet provide.

Therefore, Roche invests heavily in research and development and will continue to do so in the future.